目次

Table of Contents

1. Gynecology Drugs Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction
6.1. Segmentation By Geography
6.2. Segmentation By Therapeutics
6.3. Segmentation By Indication
6.4. Segmentation By Distribution Channel

7. Gynecology Drugs Market Characteristics
7.1. Market Definition
7.2. Market Segmentation By Therapeutics
7.2.1. Hormonal Therapy
7.2.2. Non-Hormonal Therapy
7.3. Market Segmentation By Indication
7.3.1. Gynecology Cancers
7.3.2. Menopausal Disorder
7.3.3. Polycystic Ovary Syndrome
7.3.4. Contraception
7.3.5. Others
7.4. Market Segmentation By Distribution Channel
7.4.1. Hospital Pharmacies
7.4.2. Retail Pharmacies
7.4.3. Online Pharmacies

8. Gynecology Drugs Market Trends And Strategies
8.1. New Treatment Developments
8.2. Benefits and Treatment Modalities of Menopausal Hormone Therapy
8.3. Increase In Investment In Gynecology Drugs Research
8.4. Societal Change About Contraception In Emerging Markets
8.5. Antibody-Drug Conjugates (ADCs) Targeted Therapy
8.6. Strategic Collaborations And Partnerships
8.7. Combination Therapies

9. Impact Of COVID-19 On The Gynecology Drugs Market
9.1. Impact On Gynecological Patient Care
9.2. Impact On Clinical Trial Management
9.3. Supply Chain Issues
9.4. Future Outlook

10. Global Gynecology Drugs Market Size And Growth
10.1. Market Size
10.2. Historic Market Growth, 2016 - 2021, Value ($ Million)
10.2.1. Drivers Of The Market 2016 - 2021
10.2.2. Restraints On The Market 2016 - 2021
10.3. Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
10.3.1. Drivers Of The Market 2021-2026
10.3.2. Restraints On The Market 2021-2026

11. Global Gynecology Drugs Market Segmentation
11.1. Global Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.2. Global Gynecology Drugs Market, Segmentation By Indication, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.3. Global Gynecology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

12. Gynecology Drugs Market, Regional And Country Analysis
12.1. Global Gynecology Drugs Market, By Region, Historic and Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.2. Global Gynecology Drugs Market, By Country, Historic and Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

13. Asia-Pacific Gynecology Drugs Market
13.1. Asia-Pacific Gynecology Drugs Market Overview
13.1.1. Region Information
13.1.2. Market Information
13.1.3. Background Information
13.1.4. Government Initiatives
13.1.5. Regulations
13.1.6. Regulatory Bodies
13.1.7. Major Associations
13.1.8. Taxes Levied
13.1.9. Corporate Tax Structure
13.1.10. Investments
13.1.11. Major Companies
13.2. Asia-Pacific Gynecology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.3. Asia-Pacific Gynecology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.4. Asia-Pacific Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.5. Asia-Pacific Gynecology Drugs Market: Country Analysis
13.6. China Gynecology Drugs Market
13.7. China Gynecology Drugs Market Overview
13.7.1. Country Information
13.7.2. Market Information
13.7.3. Background Information
13.7.4. Government Initiatives
13.7.5. Regulations
13.7.6. Regulatory Bodies
13.7.7. Major Associations
13.7.8. Taxes Levied
13.7.9. Corporate Tax Structure
13.7.10. Investments
13.7.11. Major Companies
13.8. China Gynecology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.9. China Gynecology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.10. China Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.11. India Gynecology Drugs Market
13.12. India Gynecology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.13. India Gynecology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.14. India Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.15. Japan Gynecology Drugs Market
13.16. Japan Gynecology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.17. Japan Gynecology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.18. Japan Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.19. Australia Gynecology Drugs Market
13.20. Australia Gynecology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.21. Australia Gynecology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.22. Australia Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.23. Indonesia Gynecology Drugs Market
13.24. Indonesia Gynecology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.25. Indonesia Gynecology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.26. Indonesia Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.27. South Korea Gynecology Drugs Market
13.28. South Korea Gynecology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.29. South Korea Gynecology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.30. South Korea Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

14. Western Europe Gynecology Drugs Market
14.1. Western Europe Gynecology Drugs Market Overview
14.1.1. Region Information
14.1.2. Market Information
14.1.3. Background Information
14.1.4. Government Initiatives
14.1.5. Regulations
14.1.6. Regulatory bodies
14.1.7. Major Associations
14.1.8. Taxes levied
14.1.9. Corporate tax structure
14.1.10. Investments
14.1.11. Major Companies
14.2. Western Europe Gynecology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
14.3. Western Europe Gynecology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
14.4. Western Europe Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.5. Western Europe Gynecology Drugs Market: Country Analysis
14.6. UK Gynecology Drugs Market
14.7. UK Gynecology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
14.8. UK Gynecology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
14.9. UK Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.10. Germany Gynecology Drugs Market
14.11. Germany Gynecology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
14.12. Germany Gynecology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
14.13. Germany Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.14. France Gynecology Drugs Market
14.15. France Gynecology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
14.16. France Gynecology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
14.17. France Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

15. Eastern Europe Gynecology Drugs Market
15.1. Eastern Europe Gynecology Drugs Overview
15.1.1. Region Information
15.1.2. Market Information
15.1.3. Background Information
15.1.4. Government Initiative
15.1.5. Regulations
15.1.6. Regulatory Bodies
15.1.7. Major Associations
15.1.8. Corporate Tax Structure
15.1.9. Investments
15.1.10. Major Companies
15.2. Eastern Europe Gynecology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.3. Eastern Europe Gynecology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.4. Eastern Europe Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.5. Eastern Europe Gynecology Drugs Market: Country Analysis
15.6. Russia Gynecology Drugs Market
15.7. Russia Gynecology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.8. Russia Gynecology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.9. Russia Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

16. North America Gynecology Drugs Market
16.1. North America Gynecology Drugs Overview
16.1.1. Region Information
16.1.2. Market Information
16.1.3. Background information
16.1.4. Government Initiatives
16.1.5. Regulations
16.1.6. Regulatory Bodies
16.1.7. Taxes Levied
16.1.8. Corporate Tax Structure
16.1.9. Investments
16.1.10. Major Companies
16.2. North America Gynecology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
16.3. North America Gynecology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
16.4. North America Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16.5. North America Gynecology Drugs Market: Country Analysis
16.6. USA Gynecology Drugs Market
16.7. USA Gynecology Drugs Overview
16.7.1. Country Information
16.7.2. Market Information
16.7.3. Background Information
16.7.4. Government Initiatives
16.7.5. Regulations
16.7.6. Regulatory Bodies
16.7.7. Taxes Levied
16.7.8. Corporate Tax Structure
16.7.9. Investments
16.7.10. Major Companies
16.8. USA Gynecology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
16.9. USA Gynecology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
16.10. USA Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

17. South America Gynecology Drugs Market
17.1. South America Gynecology Drugs Market Overview
17.1.1. Region Information
17.1.2. Market Information
17.1.3. Background Information
17.1.4. Regulations
17.1.5. Regulatory Bodies
17.1.6. Major Associations
17.1.7. Taxes Levied
17.1.8. Corporate Tax Structure
17.1.9. Major Companies
17.2. South America Gynecology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
17.3. South America Gynecology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
17.4. South America Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17.5. South America Gynecology Drugs Market: Country Analysis
17.6. Brazil Gynecology Drugs Market
17.7. Brazil Gynecology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
17.8. Brazil Gynecology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
17.9. Brazil Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

18. Middle East Gynecology Drugs Market
18.1. Middle East Gynecology Drugs Market Overview
18.1.1. Region Information
18.1.2. Market Information
18.1.3. Background Information
18.1.4. Government Initiatives
18.1.5. Regulations
18.1.6. Regulatory Bodies
18.1.7. Major Associations
18.1.8. Taxes Levied
18.1.9. Corporate Tax Structure
18.1.10. Investments
18.1.11. Major Companies
18.2. Middle East Gynecology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
18.3. Middle East Gynecology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
18.4. Middle East Drugs market, Segmentation By Therapeutics, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

19. Africa Gynecology Drugs Market
19.1. Africa Gynecology Drugs Market Overview
19.1.1. Region Information
19.1.2. Market Information
19.1.3. Background Information
19.1.4. Government Initiatives
19.1.5. Regulations
19.1.6. Regulatory Bodies
19.1.7. Major Associations
19.1.8. Taxes Levied
19.1.9. Corporate Tax Structure
19.1.10. Investments
19.1.11. Major Companies
19.2. Africa Gynecology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
19.3. Africa Gynecology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
19.4. Africa Gynecology Drugs Market, Segmentation By Therapeutics, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

20. Gynecology Drugs Global Market Competitive Landscape
20.1. Company Profiles
20.2. Merck & Co. Inc.
20.2.1. Company Overview
20.2.2. Products And Services
20.2.3. Business Strategy
20.2.4. Financial Overview
20.3. AbbVie
20.3.1. Company Overview
20.3.2. Products And Services
20.3.3. Business Strategy
20.3.4. Financial Overview
20.4. F. Hoffmann-La Roche Ltd.
20.4.1. Company Overview
20.4.2. Products And Services
20.4.3. Financial Overview
20.5. GlaxoSmithKline Plc
20.5.1. Company Overview
20.5.2. Products And Services
20.5.3. Business Strategy
20.5.4. Financial Overview
20.6. Pfizer Inc.
20.6.1. Company Overview
20.6.2. Products And Services
20.6.3. Business Strategy
20.6.4. Financial Overview

21. Key Mergers And Acquisitions In The Gynecology Drugs Market
21.1. Bharat Serums & Vaccines Acquired Women Health Brand Tidilan
21.2. Carlyle And PAI Partners Agreed To Acquired Theramex
21.3. Organon Acquired Forendo Pharma
21.4. Bayer Acquired KaNDy Therapeutics
21.5. AbbVie Acquired Allergan
21.6. Norgine Acquired Azanta
21.7. True North Acquired Glenmark Pharmaceutical Ltd Gynecology Business

22. Gynecology Drugs Market Opportunities And Strategies
22.1. Global Gynecology Drugs Market In 2026 - Countries Offering Most New Opportunities
22.2. Global Gynecology Drugs Market In 2026 - Segments Offering Most New Opportunities
22.3. Global Gynecology Drugs Market In 2026 - Growth Strategies
22.3.1. Market Trend Based Strategies
22.3.2. Competitor Strategies

23. Gynecology Drugs Market, Conclusions And Recommendations
23.1. Conclusions
23.2. Recommendations
23.2.1. Product
23.2.2. Place
23.2.3. Price
23.2.4. Promotion
23.2.5. People

24. Appendix
24.1. Market Data Sources
24.2. Research Methodology
24.3. Currencies
24.4. Research Inquiries
24.5. The Business Research Company
24.6. Copyright and Disclaimer